When will there be a generic for gemtesa?

Gemtesa is vibegron (for overactive bladder). As of my latest knowledge (2024), there isn’t a confirmed, publicly announced generic launch date for vibegron in the US.

A generic typically becomes available only after relevant patent/exclusivity periods end and the FDA approves an ANDA (or a related pathway). For exact timing, the most reliable way is to check the FDA’s Orange Book entry for vibegron (Gemtesa) or look for an approved ANDA/FDA tentative approval announcements.

If you tell me your country (US/Canada/EU/etc.) and whether you mean immediate-release vs. the specific dose/strength, I can point you to the right place to verify the likely window.